COO
COOPER COMPANIES, INC.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$63.51
−1.41%Price chart
Oct 7Oct 12Oct 15Oct 20Oct 23Oct 28Nov 2Nov 5
Key dataNov 5, 2026
Open$65.40
From 52W high−24.68%
Volume2.37M
Market cap$12.08B
P/E (TTM)21.7x
P/S (TTM)2.9x
Div yield—
Key dataNov 5, 2026
Open
$65.40
From 52W high
−24.68%
Volume
2.37M
Market cap
$12.08B
ValuationView details →
P/E (Fwd)
13.7x
EV/EBITDA
15.9x
P/E (TTM)
21.7x
RSI (14)
62.5
MomentumView details →
1D Return
−1.41%
YTD Return
−22.61%
SummaryUpdated Jul 1, 2026
The Cooper Companies, Inc. (NYSE:COO) is a global medical device company founded in 1958 and headquartered in San Ramon, California. The company has evolved from its origins into a leading manufacturer of contact lenses and women's healthcare products. Cooper Companies went public in 1983 and has grown through strategic acquisitions and organic expansion to become a significant player in the medical devices industry, operating in over 100 countries worldwide with annual revenues approaching $4 billion.
Similar companies
Latest newsMore news →
COOPER COMPANIES, INC. announced that it will release its fourth-quarter and full-year 2026 financial results on December 3, 2026, and host a conference call afterward.10h agoAlbert G. White III resigned as President and Chief Executive Officer of Cooper Companies, effective October 27, 2026.9d agoCOOPER COMPANIES, INC. elected independent director Walt Rosebrough as executive chair and said a search for a CEO is underway.10d ago